India News
-
CMOs look towards Asia to reduce cost by 50%
India | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2012
Singapore: Global contract manufacturing organizations (CMOs) are set to steadily become more and more popular, as Western pharmaceutical companies outsource production to Asian countries i...Read more
-
InnoPack Pharma to be held from June 27-28
India | News | By BioSpectrum Bureau | 0 Comment | 15 Apr, 2013
Singapore: The second edition of InnoPack Pharma would be held from June 27-28, 2013, in Mumbai, India. The conference is expected to see participation from over 150 professionals belonging...Read more
-
Industry-academia meet focuses on innovation in India
India | News | By Rahul Koul Koul | 0 Comment | 22 Oct, 2012
New Delhi: India's department of biotechnology (DBT) and biotechnology industry research assistance council (BIRAC) have for the first time ever held a meeting called 'Innovation for Afford...Read more
-
Wockhardt to market generic of GSK Parkinson's drug
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2012
Mumbai: Pharmaceutical and biotechnology major Wockhardt received US FDA approval for marketing 2mg, 4mg, 6mg, 8mg and 12mg extended-release tablets with generic version of GlaxoSmithKline'...Read more
-
Pharma companies set eyes on China
India | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more
-
5 major policy developments of 2012
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Dec, 2012
The Year 2012 has seen crucial policy changes in the bioscience industry around the world. These changes that have taken place in 2012 hope to have an impact on the businesses of pharma, bi...Read more
-
50 Indian companies to invest $500mn in the US
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Hyderabad: 50 Indian companies have recently indicated they will collectively invest over $500 million in the US market by either acquiring a US business or setting up their own operations...Read more
-
Lupin gets approval for oral contraceptive
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Bangalore: Pharma major, Lupin, announced that its subsidiary Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its oral contraceptive Kurvelo® Tablets (Levo...Read more
-
What the future holds for the APAC CRO market?
India | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more
-
Indo-Aussie research to find ovarian cancer cure
India | News | By BioSpectrum Bureau | 0 Comment | 04 Oct, 2012
Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more
-
India | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2012
Singapore: Right on time with the soon expected registrations of the joimax products in Brazil - one of the most emerging BRIC economies - the German-based company showed a very successful...Read more
-
Eli Lilly, Strides expand in emerging markets
India | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Bangalore: Eli Lilly and Company and Strides Arcolab have entered into a collaboration to expand delivery of cancer medicines in the emerging markets. As a part of this arrangement, Lilly ...Read more
-
Aventis Pharma renamed to 'Sanofi India Ltd'
India | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
Bangalore: The Sanofi Group recently announced the company's change of name from Aventis Pharma Limited to 'Sanofi India Limited', effective May 11, 2012. Aventis Pharma Limited is the grou...Read more
-
Phoenix's heart repair device trial is underway
India | News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013
Singapore: Phoenix Cardiac Devices, a medical device company with a novel method of repairing leaky heart valves without open-heart surgery, has enrolled its first patient in a clinical tri...Read more
-
Global collaborations is the way forward for drug discovery
India | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma through a multitude of outsourcing deals. A large...Read more
-
India caps FDI in pharma at 49%
India | News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2012
Bangalore: An inter-ministerial group (IMG) on foreign direct investment (FDI) in pharmaceuticals, headed by Mr Shanktikanta Das, additional secretary, Department of Economic Affairs (DEA),...Read more
-
BMS Foundation awards $1.6 mn to fight diabetes in India
India | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2012
Singapore: Bristol-Myers Squibb (BMS) Foundation will provide $1.6 million in grants to four healthcare institutions in India to help improve diabetes education, prevention and care, increa...Read more
-
Serum Institute acquires Dutch biologics company
India | News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2012
Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine company, has acquired Bilthoven Biologicals of Netherlands. Through the...Read more
